Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association
Authors:
- Shaine A. MorrisSMShaine A. Morris
- Jonathan N. FlyerJFJonathan N. Flyer
- Anji T. YetmanAYAnji T. Yetman
- Emilio QuezadaEQEmilio Quezada
- Elizabeth S. CappellaECElizabeth S. Cappella
- Harry C. DietzHDHarry C. Dietz
- Dianna M. MilewiczDMDianna M. Milewicz
- Maral OuzounianMOMaral Ouzounian
- Christina M. RigelskyCRChristina M. Rigelsky
- Seda TierneySTSeda Tierney
- Ronald V. LacroRLRonald V. Lacro
Top Cited Papers
- 10 September 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (11) , e228-e254
Abstract
Aortopathy encompasses a spectrum of conditions predisposing to dilation, aneurysm, dissection, or rupture of the aorta and other blood vessels. Aortopathy is diagnosed commonly in children, from infancy through adolescence, primarily affecting the thoracic aorta, with variable involvement of the peripheral vasculature. Pathogeneses include connective tissue disorders, smooth muscle contraction disorders, and congenital heart disease, including bicuspid aortic valve, among others. The American Heart Association has published guidelines for diagnosis and management of thoracic aortic disease. However, these guidelines are predominantly focused on adults and cannot be applied adeptly to growing children with emerging features, growth and developmental changes, including puberty, and different risk profiles compared with adults. Management to reduce risk of progressive aortic dilation and dissection or rupture in children is complex and involves genetic testing, cardiovascular imaging, medical therapy, lifestyle modifications, and surgical guidance that differ in many ways from adult management. Pediatric practice varies widely, likely because aortopathy is pathogenically heterogeneous, including genetic and nongenetic conditions, and there is limited published evidence to guide care in children. To optimize care and reduce variation in management, experts in pediatric aortopathy convened to generate this scientific statement regarding the cardiovascular care of children with aortopathy. Available evidence and expert consensus were combined to create this scientific statement. The most common causes of pediatric aortopathy are reviewed. This document provides a general framework for cardiovascular management of aortopathy in children, while allowing for modification based on the personal and familial characteristics of each child and family.Keywords
This publication has 144 references indexed in Scilit:
- Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic DissectionJAMA Cardiology, 2023
- Association of Mitral Annular Disjunction With Cardiovascular Outcomes Among Patients With Marfan SyndromeJAMA Cardiology, 2021
- Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patientsCatheterization and Cardiovascular Interventions, 2021
- Thoracic aortic aneurysm in patients with loss of function Filamin A mutations: Clinical characterization, genetics, and recommendationsAmerican Journal of Medical Genetics Part A, 2018
- The 2017 international classification of the Ehlers–Danlos syndromesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2017
- Clinical utility of a next generation sequencing panel assay for Marfan and Marfan‐like syndromes featuring aortopathyAmerican Journal of Medical Genetics Part A, 2015
- Acute aortic dissections with pregnancy in women with ACTA2 mutationsAmerican Journal of Medical Genetics Part A, 2013
- De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunctionAmerican Journal of Medical Genetics Part A, 2010
- Mutation ofACTA2gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD)Human Mutation, 2009
- Angiotensin II receptor antagonist treatment during pregnancyBirth Defects Research Part A: Clinical and Molecular Teratology, 2005